Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2010
05/19/2010CN101019985B Constipation treating Chinese medicine
05/19/2010CN101019984B Constipation treating Chinese medicine preparation
05/19/2010CN101019938B Chinese medicine for treating enteritis and colitis and its preparation method
05/19/2010CN101015326B Wax-free aged honeycomb beverage and its preparing process
05/19/2010CN101011577B Polyamide dendroid polymer nano particle loading survivin small molecule RNA
05/19/2010CN101011531B Medicine for treating children's anorexia and repetitive infection and its preparing method
05/19/2010CN101011176B Healthy drink for reinforcing stomach and building a healthy body and production method thereof
05/19/2010CN101011171B Dried orange peel aurantium tea beverage and its production method
05/19/2010CN101011118B Infant nutrient honey and processing method thereof
05/19/2010CN101007009B A drug for preventing and treating liver injury and lowering blood fat
05/19/2010CN101006984B An injection preparation containing salvianolic acid A and extract of panax natoginseng, and its preparation method and application
05/19/2010CN101006975B An oral medicine preparation containing salvianolic acid A and extract of panax natoginseng, and its preparation method and application
05/19/2010CN100998693B Health-care medicated wine made of traditional Chinese medicines
05/19/2010CN100998592B Microemulsion containing matrine
05/19/2010CN100998426B Method for improving quality of fish meat by adding chitin
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718670 antagonists of M3 muscarinic receptors; N-(1-Azabicyclo[2.2.2]oct-3-yl)-2-hydroxy-2,2-dithien-2-ylacetamide; respiratory disorders, urological disorders, gastrointestinal disorders, cardiovascular disorders; reaction with organometallic derivative
05/18/2010US7718646 Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same
05/18/2010US7718623 Immunostimulatory oligonucleotide that induces interferon alpha
05/18/2010US7718376 Identification and isolation of somatic stem cells and uses thereof
05/18/2010US7718200 Plant extract mixtures and their uses
05/18/2010US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof
05/18/2010CA2616119C Method of preparing esomeprazole and salts thereof
05/18/2010CA2509715C Improved thickened beverages for dysphagia
05/18/2010CA2472475C 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2407287C Method of forming vertebrate pancreas in vitro
05/18/2010CA2383357C Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues
05/18/2010CA2368965C Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
05/18/2010CA2355716C Benzisoxazoles and phenones as .alpha.2-antagonists
05/18/2010CA2304204C Quinoline-containing .alpha.-ketoamide cysteine and serine protease inhibitors
05/18/2010CA2131797C Condensed indole derivatives as 5ht4-receptor antagonists
05/14/2010WO2010054083A2 Inhalation formulation for treating and prophylatic use in bacteria, mycobacterial and fungal respiratory infections
05/14/2010WO2010054003A2 Methylindazole modulators of 5-ht3 receptors
05/14/2010WO2010053182A1 Kynurenine production inhibitor
05/14/2010WO2010053085A1 Agent for preventing acidosis in ruminant animals
05/14/2010WO2010052467A2 Canine oral cavity probiotics
05/14/2010WO2010052027A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease
05/14/2010WO2010051683A1 A composition useful for treating acute enteritis and diarrhea
05/14/2010WO2010033292A9 Method for medical treatment utilizing l-glutathione
05/14/2010WO2010025483A8 Treatment of fructose malabsorption
05/14/2010WO2010025267A3 Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
05/14/2010WO2010011599A3 Pimethixene derivatives for promoting bone growth
05/14/2010WO2010005868A3 A vaccine for porcine post-weaning diarrhea caused by enterotoxigenic escherichia coli
05/14/2010WO2010005565A3 Method of treating glycogen storage disease
05/14/2010WO2009066309A9 Process for preparation of omeprazole
05/14/2010CA2742910A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease
05/14/2010CA2742712A1 Methods and systems for treating and controlling oral periopathogens
05/13/2010US20100120862 Monocyclic compounds and their use as trpv1 ligands
05/13/2010US20100120852 Aroyl-piperidine derivatives and method of treating disorders induced by substance p
05/13/2010US20100120850 Quinoline Derivatives, Pharmaceutical Compositions Comprising Them, and Their Use in Treating Central Nervous System and Peripheral Diseases
05/13/2010US20100120844 Tetrahydroisoquinoline compound
05/13/2010US20100120839 Pyrazoles useful in the treatment of inflammation
05/13/2010US20100120813 Peripheral opioid receptor antagonists and uses thereof
05/13/2010US20100120808 Spirocyclic heterocyclic derivatives and methods of their use
05/13/2010US20100120807 Compounds and compositions as modulators of gpr119 activity
05/13/2010US20100120802 Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production
05/13/2010US20100120794 Cycloalkylamino Acid Derivatives
05/13/2010US20100120778 Quinoxaline-based lxr modulators
05/13/2010US20100120775 Farnesoid X Receptor Agonists
05/13/2010US20100120766 Substituted Pteridines
05/13/2010US20100120762 Triazine derivatives as inhibitors of phosphodiesterases
05/13/2010US20100120749 Tetrahydroindole derivatives as nadph oxidase inhibitors
05/13/2010US20100120747 Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
05/13/2010US20100120731 3-([1,2,4]triazolo [4,3-a]pyridin-7-yl)benzamide derivatives
05/13/2010US20100120730 6-benzyl-2,3,4,7-tetrahydro-indolo [2,3-c] quinoline compounds useful as pde5 inhibitors
05/13/2010US20100120722 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
05/13/2010US20100120705 Compositions and products containing s-equol, and methods for their making
05/13/2010US20100120704 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders
05/13/2010US20100120703 Compositions and methods for treating cancer
05/13/2010US20100120676 Composition to treat and/or prevent gastrointestinal infection
05/13/2010US20100120667 Composition for preventing and/or treating peptic ulcers
05/13/2010US20100120660 Highly concentrated insulin solutions and compositions
05/13/2010US20100119623 Imidazolyl modulators of 5-ht3 receptors
05/13/2010US20100119561 Compositions Having a Performance Indicator
05/13/2010US20100119555 Methods and Compositions for the Treatment and Diagnosis of Cancer
05/13/2010US20100119521 Compositions and methods for treating cancer by modulating her-2 and egf receptors
05/13/2010US20100119497 Probiotics to reduce episodes of diarrhoea in infants born by caesarean section
05/13/2010US20100119488 Probiotics to improve gut microbiota
05/13/2010US20100119453 Methods of enhancing functioning of the large intestine
05/12/2010EP2184279A1 Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof
05/12/2010EP2184062A1 Use of glutamic acid and a nucleic acid as metabotropic glutamate receptor activators
05/12/2010EP2183249A1 8-azabicycloý3.2.1¨octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
05/12/2010EP2183027A1 Organic compounds
05/12/2010EP1870409B1 Benzimidazole compounds
05/12/2010EP1519933B1 Quinuclidine amide derivatives
05/12/2010EP1373262B1 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors
05/12/2010CN1993350B Salt of benzimidazole derivative with amine, and process for producing the same
05/12/2010CN1985987B Medicine composition of glycyrrhizic acid or its salt and reduced glutathione
05/12/2010CN1985864B Medicine composition prepared mainly from glycyrrhizic acid or its salt, ginseng and glossy ganoderma
05/12/2010CN1977921B Chinese medicine preparation for treating hepatitis and anti-fulminant hepatitis, and its preparing method and use
05/12/2010CN1973839B Nizatidine injection
05/12/2010CN1965897B Chinese medicinal composition for resisting hepatic fibrosis and method for preparing same
05/12/2010CN1943600B Medicinal composition containing American cockroach and its ethanol extract and new use
05/12/2010CN1931230B Isodon lophanthoides extract and its preparation process and application
05/12/2010CN1927232B Ganoderma lucidum spore powder and process for preparing capsule thereof
05/12/2010CN1927220B Montmorillonite gelling preparation for treating diarrhea and gastritis and its preparation process
05/12/2010CN1927050B DHA microcapsule food additives, DHA soft capsule health product and uses thereof
1 ... 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 ... 1258